COM:NANTHEALTH
NantHealth
- Stock
Last Close
1.35
14/11 21:00
Market Cap
10.40M
Beta: -
Volume Today
197.97K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 2.55M - | 2.18M 14.32% | 1.53M 29.96% | 667.50K 56.32% | 647K 3.07% | 399K 38.33% | ||||
average payables | 5.29M - | 6.58M 24.42% | 4.94M 24.93% | 2.41M 51.30% | 2.80M 16.35% | 4.54M 61.99% | 4.16M 8.23% | 6.81M 63.49% | ||
average receivables | 9.14M - | 14.92M 63.27% | 13.35M 10.51% | 14.18M 6.24% | 14.02M 1.18% | 8.02M 42.77% | 5.31M 33.81% | 7.00M 31.73% | ||
book value per share | 8.05 - | 22.99 185.50% | 55.32 140.68% | 24.84 55.10% | 0.39 98.43% | -7.77 2,096.59% | -15.11 94.58% | -21.29 40.86% | -29.26 37.46% | |
capex per share | -1.45 - | -1.65 13.81% | -2.12 28.90% | -1.75 17.39% | -1.45 17.30% | -0.62 56.94% | -0.77 22.90% | -0.67 12.93% | -0.84 25.82% | |
capex to depreciation | -0.72 - | -0.84 16.62% | -0.51 39.19% | -0.49 4.72% | -0.47 2.94% | -0.21 56.49% | -0.34 64.78% | -0.32 4.45% | -0.40 25.21% | |
capex to operating cash flow | 0.28 - | 0.17 36.69% | 0.22 27.78% | 0.17 24.78% | 0.36 111.80% | 0.52 47.14% | 0.34 35.74% | 0.18 45.47% | 0.20 9.30% | |
capex to revenue | -0.34 - | -0.23 33.79% | -0.16 30.79% | -0.16 0.08% | -0.12 25.07% | -0.05 59.42% | -0.08 62.06% | -0.08 4.63% | -0.10 19.08% | |
cash per share | 28.03 - | 0.90 96.79% | 21.55 2,298.71% | 7.92 63.24% | 2.52 68.25% | 0.71 71.66% | 3.08 332.25% | 3.82 24.06% | 0.23 94.02% | |
days of inventory on hand | 44.38 - | 22.50 49.29% | 11.19 50.29% | 7.38 34.07% | 4.09 44.55% | 7.58 85.37% | ||||
days payables outstanding | 62.30 - | 67.60 8.50% | 33.91 49.84% | 27.81 17.98% | 13.60 51.09% | 37.53 175.89% | 63.97 70.43% | 42.06 34.25% | 131.73 213.22% | |
days sales outstanding | 32.97 - | 95.23 188.83% | 53.19 44.15% | 50.85 4.39% | 66.47 30.72% | 44.66 32.82% | 21.47 51.93% | 36.80 71.40% | 41.80 13.61% | |
debt to assets | 0.79 - | 0.55 30.40% | 0.40 27.66% | 0.57 42.94% | 0.99 73.80% | 1.21 22.65% | 1.56 28.15% | 1.82 16.88% | 2.41 32.65% | |
debt to equity | 3.80 - | 1.23 67.70% | 0.66 45.99% | 1.32 99.80% | 100.14 7,464.85% | -5.66 105.66% | -2.79 50.77% | -2.22 20.34% | -1.71 23.11% | |
dividend yield | ||||||||||
earnings yield | -0.04 - | -0.03 14.70% | -0.17 417.26% | -0.49 196.51% | -3.23 557.26% | -0.55 82.96% | -0.25 55.23% | -0.49 97.07% | -2.41 395.71% | |
enterprise value | 2.28B - | 2.24B 1.62% | 1.14B 49.07% | 489.85M 57.03% | 241.58M 50.68% | 325.85M 34.88% | 556.69M 70.84% | 347.91M 37.50% | 293.76M 15.56% | |
enterprise value over ebitda | -33.83 - | -40.56 19.90% | -6.72 83.43% | -3.68 45.27% | -1.55 57.99% | -8.92 477.48% | -8.65 3.10% | -8.69 0.48% | -7.73 10.98% | |
ev to operating cash flow | -54.00 - | -29.55 45.28% | -16.14 45.38% | -6.04 62.60% | -8.15 35.06% | -37.18 355.99% | -33.03 11.15% | -12.56 61.96% | -9.10 27.54% | |
ev to sales | 67.07 - | 38.39 42.76% | 11.36 70.42% | 5.65 50.24% | 2.70 52.22% | 3.40 25.75% | 7.61 124.05% | 5.55 27.01% | 4.38 21.05% | |
free cash flow per share | -6.68 - | -11.06 65.50% | -11.61 5.05% | -12.18 4.86% | -5.52 54.67% | -1.82 67.12% | -3.05 67.75% | -4.31 41.41% | -5.03 16.78% | |
free cash flow yield | -0.02 - | -0.04 65.50% | -0.08 96.46% | -0.27 241.74% | -0.68 154.04% | -0.12 82.63% | -0.06 46.51% | -0.27 332.93% | -1.38 406.30% | |
graham net net | -2.08 - | -25.75 1,138.48% | -13.48 47.65% | -23.74 76.13% | -34.73 46.28% | -42.03 21.02% | -38.62 8.10% | -42.84 10.92% | -49.00 14.38% | |
graham number | 43.59 - | 68.02 56.05% | 175.50 158.01% | 112.17 36.09% | 15.20 86.45% | 38.57 153.76% | 63.76 65.29% | 60.71 4.78% | 76.11 25.36% | |
income quality | 0.50 - | 1.05 110.77% | 0.38 63.53% | 0.46 20.71% | 0.15 66.70% | 0.14 9.44% | 0.30 113.80% | 0.47 58.40% | 0.48 0.64% | |
intangibles to total assets | 0.21 - | 0.27 27.96% | 0.37 34.85% | 0.41 12.07% | 0.63 53.96% | 0.63 0.20% | 0.73 16.02% | 0.69 4.94% | 0.81 15.93% | |
interest coverage | -86.41 - | -113.08 30.87% | -25.47 77.47% | -4.20 83.51% | -2.96 29.48% | -1.48 49.86% | -1.33 10.42% | -2.82 112.33% | -3.64 28.71% | |
interest debt per share | 0.12 - | 0.08 36.02% | 26.53 33,956.01% | 27.19 2.50% | 29.90 9.95% | 32.01 7.05% | 32.49 1.49% | 35.62 9.64% | 36.55 2.61% | |
inventory turnover | 8.22 - | 16.22 97.22% | 32.63 101.15% | 49.49 51.68% | 89.25 80.34% | 48.15 46.05% | ||||
invested capital | 0.46 - | 1.01 117.85% | 70.81 6,903.38% | -3.81 105.37% | -1.98 48.03% | -1.58 19.92% | -1.19 25.09% | |||
market cap | 2.24B - | 2.24B 0% | 1.11B 50.57% | 356.05M 67.90% | 59.41M 83.31% | 113.66M 91.32% | 358.38M 215.31% | 120.43M 66.40% | 28.12M 76.65% | |
net current asset value | -12.86M - | -193.92M 1,408.42% | -87.13M 55.07% | -174M 99.69% | -244.06M 40.27% | -285.71M 17.06% | -281.09M 1.62% | -320.41M 13.99% | -372.36M 16.21% | |
net debt to ebitda | -0.46 - | 0.11 123.70% | -0.18 266.70% | -1.00 455.33% | -1.17 15.99% | -5.81 398.68% | -3.08 46.99% | -5.68 84.44% | -6.99 23.11% | |
net income per share | -10.49 - | -8.95 14.70% | -24.74 176.58% | -22.51 9.02% | -26.40 17.27% | -8.52 67.75% | -11.96 40.41% | -7.70 35.63% | -8.80 14.33% | |
operating cash flow per share | -5.23 - | -9.41 79.78% | -9.49 0.88% | -10.43 9.83% | -4.07 60.95% | -1.19 70.74% | -2.28 91.24% | -3.64 59.69% | -4.19 15.12% | |
payables turnover | 5.86 - | 5.40 7.84% | 10.76 99.36% | 13.12 21.92% | 26.83 104.44% | 9.72 63.75% | 5.71 41.32% | 8.68 52.10% | 2.77 68.07% | |
receivables turnover | 11.07 - | 3.83 65.38% | 6.86 79.04% | 7.18 4.59% | 5.49 23.50% | 8.17 48.85% | 17.00 108.01% | 9.92 41.66% | 8.73 11.98% | |
research and ddevelopement to revenue | 0.50 - | 0.41 18.33% | 0.61 50.20% | 0.39 36.38% | 0.23 40.16% | 0.20 14.99% | 0.24 18.78% | 0.31 33.25% | 0.34 9.35% | |
return on tangible assets | -0.34 - | -0.24 30.40% | -0.42 76.83% | -0.66 55.82% | -1.82 175.09% | -0.63 65.09% | -1.64 158.13% | -0.97 40.87% | -2.18 124.91% | |
revenue per share | 4.21 - | 7.24 71.88% | 13.49 86.25% | 11.14 17.45% | 12.29 10.37% | 13.04 6.11% | 9.89 24.16% | 8.23 16.78% | 8.70 5.66% | |
roe | -1.30 - | -0.39 70.12% | -0.45 14.91% | -0.91 102.64% | -67.87 7,388.24% | 1.10 101.62% | 0.79 27.84% | 0.36 54.30% | 0.30 16.82% | |
roic | -0.28 - | -0.18 35.95% | -0.40 122.22% | -0.21 48.61% | -0.20 3.11% | -0.11 47.08% | -0.17 61.70% | -0.30 74.97% | -0.35 16.85% | |
sales general and administrative to revenue | 1.20 - | 0.87 28.03% | 0.79 8.56% | |||||||
shareholders equity per share | 8.05 - | 22.99 185.50% | 55.32 140.68% | 24.84 55.10% | 0.39 98.43% | -7.77 2,096.59% | -15.11 94.58% | -21.29 40.86% | -29.26 37.46% | |
stock based compensation to revenue | 0.01 - | 0.02 144.53% | 0.54 2,092.94% | 0.05 90.32% | 0.06 21.50% | 0.03 54.09% | 0.04 24.65% | 0.06 71.45% | 0.07 12.22% | |
tangible asset value | -1.07M - | 73.32M 6,977.67% | 161.40M 120.14% | 9.25M 94.27% | -177.80M 2,021.56% | -224.91M 26.50% | -257.70M 14.58% | -299.36M 16.17% | -353.84M 18.20% | |
tangible book value per share | -0.13 - | 9.11 6,977.67% | 21.69 138.16% | 1.19 94.52% | -24.43 2,154.79% | -30.57 25.14% | -34.84 13.96% | -39.34 12.92% | -45.94 16.77% | |
working capital | 146.22M - | -10.21M 106.98% | 128.33M 1,356.90% | 46.03M 64.13% | 2.91M 93.68% | -19.59M 773.59% | -94.16M 380.72% | 11.46M 112.18% | -23.05M 301.01% |
All numbers in (except ratios and percentages)